1.Ramaswamy S，Musser JM.Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis：1998update.Tuberc Lung Dis，1998，79：3-29.
2.Cole ST.The molecular basis of drug resistance.In：Porter JDH，McAdam KPW，editors.Tuberculosis –back to the future.Chicester：John Wiley and Sons；1994p.225-230.
3.Ishihama A.Promoter selectivity of prokaryotic RNA polymerases.Trends Genet，1988，4：282-286.
4.Burgess RR，Erickson B，Gentry D，Gribstov M，Hager D，Lesley S，Strickland M，Thompson N.Bacterial RNA polymerase subunits and genes.In：Reznikoff WS，Gross CA，Burgess RR，Record MT Jr，Dahlberg JE，Wickens MP ed.RNA polymerase and the regulation of tranion.Elsevier，New York；1987p.3-15.
5.Wehrli W.Rifampin：mechanisms of action and resistance.Rev Infect Dis，1983，5：S407-S411.
6.Yamada T，Nagata A，Ono Y，Suzuki Y，Yamanouchi T.Alteration of ribosomes and RNA polymerase in drug-resistant clinical isolates of Mycobacterium tuberculosis.Antimicrob Agents Chemother.1985，27：921-924.
7.Jin D J，Gross CA.Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance.J Mol Biol，1988，202：45-58.
8.Telenti A，Imboden P，Marchesi F，et al.Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis.Lancet，1993，341：647-650.
9.Miller LP，Crawford JT，Shinnick TM.The rpoB Gene of Mycobacterium tuberculosis.Antimicrob Agents Chemother.1994，38：805-811.
10.Campbell EA，Korzheva N，Mustaev A，et al.Structural Mechanism for Rifampicin Inhibition of Bacterial RNA Polymerase.Cell，2001，104：901-912.
11.Chaves F，Alonso-Sanz M，Rebollo MJ，Tercero JC，Jimenez MS，Noriega AR.rpoB mutations as an epidemiologic marker in rifampin-resistant Mycobacterium tuberculosis.Int J Tuberc Lung Dis，2000，4：765–70.
12.Kapur V，Li LL，Iordanescu S，et al.Characterization by automated DNA sequencing of mutations in the gene （rpoB）encoding the RNA polymerase subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas.J Clin Microbiol，1994，32：1095–1098.
13.Mikhailovich V，Lapa S，Gryadunov D，et al.Identification of rifampin-resistant Mycobacterium tuberculosis strains by hybridization，PCR，and ligase detection reaction on oligonucleotide microchips.J Clin Microbiol，2001，39（7）：2531-2540.
14.Qian L，Abe C，Lin TP，et al.rpoB genotypes of Mycobacterium tuberculosis Beijing family isolates from East Asian countries.J Clin Microbiol，2002，40：1091-4.
15.Srinivas V.Ramaswamy，Dou SJ，et al.Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey，Mexico.J Med Microbiol，2004，53：107-113
16.Zhang Y，Heym B，Allen B，et a1.The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis.Nature，1992，358：591-593.
17.Saint-joanis B，Souchon H，Wilming M，et a1.Use of site directed mutagenesis to probe the structure，function and isoniazid activtion of the cata1ase/peroxidase，katG，from Mycobacterium tubercufosis.Biochem J，1999，338：753-60.
18.Heym B，Zhang Y，Poulet S，et a1.Characterization of the katG gene encoding a catalase peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis.J Bacteria1，1993，175：4255-4259.
19.Chen P，Bishai W R.Novel selection for isoniazid resistance genes supports a role for NAD+-binding proteins in mycobacterial INH resistance.Infect Immun，1998，66：5099-5106.
20.Rindi L，Bianchi L，Tortoli E，Lari N，Bonanni D，Garzelli C.Mutations responsible for Mycobacterium tuberculosis isoniazid resistance in Italy.Int J Tuberc Lung Dis，2005，9：94-97.
21.Kelley，CL，Rouse DA，Morris SL.Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis.Antimicrob.Agents Chemother，1997，41：2057-2058.
22.Herrera-Leon L，Molina T，Saiz P，Saez-Nieto JA，Jimenez MS.New multiplex PCR for rapid detection of isoniazid-resistant Mycobacterium tuberculosis clinical isolates.Antimicrob Agents Chemother.2005，49：144-7.
23.Zhang SL，Wu XQ，Zu Y.Detection of katG mutations in isoniazid-resistant Mycobacterium tuberculosis strains by polymerase chain reaction-single strand conformational polymorphism.Chin J Health Lab Tech，2000，10：185-187.
24.Cockerill FR 3rd，Uhl JR，Temesgen Z，et al.Rapid identification of a point mutation of the M ycobacterium tuberculosis catalase-peroxidase （KatG）gene associated with isoniazid resistance.J Infect Dis，1995，171：240-245.
25.Rouse DA，Li Z，Bai GH，et al.Characterization of the katG and inhA genes of isoniazid-resistant clinical isolate of Mycobacterium tuberculosis.Antimicrob Agents Chemother，1995，39：2472-2477.
26.Haas WH，Schilke K，Brand J，et al.Molecular analysis of katG gene mutations in strains of Mycobacterium tuberculosis complex from Africa.Antimicrob Agents Chemother，1997，41：1601-1603.
27.Banerjee A ，Dubnau E，Quemard A，Balasubramanian V，Um KS，Wilson T，Collins D，de Lisle G，Jacobs WR Jr.inhA，a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis.Science 1994，263：227-230.
28.Dessen A，Quemard A，Blanchard JS，Jacobs WR Jr，Sacchettini JC.Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis.Science.1995，267：1638–1641.
29.Rozwarski DA，Grant GA，Barton DH，Jacobs WR Jr，Sacchettini JC.Modification of the NADH of the isoniazid target （InhA）from Mycobacterium tuberculosis.Science.1998，279：98–102.
30.Basso LA，Zheng R，Muser JM，et a1.Mechanisms of isoniazid resistance in Mycobacterium tuberculos is：enzymatic characterization of enoyl reductase mutants identified in isoniazid-resistant clinical isolates.J Infect Dis，1998，178（3）：769-775.